Sarecycline

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Optimal Use Recommendations and Stewardship Principles with Oral Antibiotics in Acne Vulgaris Management: An Expert Consensus Panel.

Optimal Use Recommendations and Stewardship Principles with Oral Antibiotics in Acne Vulgaris Management: An Expert Consensus Panel.

Journal: The Journal of clinical and aesthetic dermatology

Published: February 05, 2026

Distinct Osteogenic Profiles of Tetracyclines from Different Generations in an Ex Vivo Embryonic Chick Femur Model.

Distinct Osteogenic Profiles of Tetracyclines from Different Generations in an Ex Vivo Embryonic Chick Femur Model.

Journal: International journal of molecular sciences

Published: January 21, 2026

Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate-to-Severe Acne.

Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate-to-Severe Acne.

Journal: Journal of cosmetic dermatology

Published: September 23, 2025

No pharmacovigilance signal of intracranial hypertension associated with glycylcyclines: a FAERS-based disproportionality analysis.

No pharmacovigilance signal of intracranial hypertension associated with glycylcyclines: a FAERS-based disproportionality analysis.

Journal: The Journal of antimicrobial chemotherapy

Published: July 24, 2025

Efficacy and Safety of Sarecycline in Chinese Patients with Moderate-to-Severe Acne Vulgaris: Randomized Phase 3 Clinical Trial with Open-Label Follow-Up.

Efficacy and Safety of Sarecycline in Chinese Patients with Moderate-to-Severe Acne Vulgaris: Randomized Phase 3 Clinical Trial with Open-Label Follow-Up.

Journal: Dermatology and therapy

Published: June 12, 2025

A Single-Center Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis.

A Single-Center Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis.

Journal: Journal of drugs in dermatology : JDD

Published: June 04, 2025

A Cross-Sectional Study Analyzing Recent Trends in the Treatment of Acne Vulgaris: Prescription Patterns and Demographic Data From the 2018-2019 National Ambulatory Medical Care Survey (NAMCS) Database.

A Cross-Sectional Study Analyzing Recent Trends in the Treatment of Acne Vulgaris: Prescription Patterns and Demographic Data From the 2018-2019 National Ambulatory Medical Care Survey (NAMCS) Database.

Journal: Cureus

Published: February 16, 2025

C10-Benzoate Esters of Anhydrotetracycline Inhibit Tetracycline Destructases and Recover Tetracycline Antibacterial Activity.

C10-Benzoate Esters of Anhydrotetracycline Inhibit Tetracycline Destructases and Recover Tetracycline Antibacterial Activity.

Journal: ACS infectious diseases

Published: February 06, 2025

Disparities in acne prescription patterns in underrepresented groups: insights from the all of us database.

Disparities in acne prescription patterns in underrepresented groups: insights from the all of us database.

Journal: Archives of dermatological research

Published: January 29, 2025

Innovations in Acne.

Innovations in Acne.

Journal: Dermatologic clinics

Published: November 14, 2024

An update on the pharmacological management of acne vulgaris: the state of the art.

An update on the pharmacological management of acne vulgaris: the state of the art.

Journal: Expert opinion on pharmacotherapy

Published: October 18, 2024

Sarecycline for moderate to severe acne: a promising narrow-spectrum antibacterial drug.

Sarecycline for moderate to severe acne: a promising narrow-spectrum antibacterial drug.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: September 18, 2024

Showing 1-12 of 83

Last Updated: 04/28/2026